Keywords: lumavita, raises, 3m, series, financing, basel, switzerland-based
Lumavita raises $16.3M in series A financing
Article | 08 September 2008
Basel, Switzerland-based Lumavita AG has completed a series A financing that raised 18.0 million Swiss francs ($16.3 million). Lead investors were Atlas ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
